Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

301 projects

  • Development of next-generation Vero cells to improve vaccine production

    Development of improved Vero cells in disposable bioreactors for enhanced vaccine production
  • The impact of probiotics on brain and behaviour.

    Unravelling probiotic’s gut-brain mechanisms for better understanding of depression and anxiety.
  • Serological markers for monitoring hepatitis B infections and hepatocellular carcinoma

    Serological hepatitis markers integrated into clinical care: towards clinical response assessment and individualized treatment decisions.
  • Pre-emptive stenting of vulnerable non-obstructive coronary lesions

    Pre-emptive, OCT guided stenting of non-obstructive vulnerable coronary lesions in patients after myocardial infarction.
  • The Dutch Acute Hepatitis C in HIV Study

    Multi-center research to study two new therapies for acute HCV infection (DAHHS study).
  • Muscle weakness and muscle loss: experimental models, intervention, and biomarkers

    Experimental models and biomarkers for functional decline to allow early diagnosis and efficient interventions.
  • Development of innovative, personalized cancer vaccines

    Treating and/or preventing cancer recurrence through personalized and tumor-specific DNA vaccines.